Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

WeightWatchers announced the departure of CEO Sima Sistani, effective immediately, and board member Tara Comonte, former ...

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

While the demand grows for popular weight loss medications like Ozempic and Wegovy, you might be interested in a more natural ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Big Joe Henry is managing his cravings and eating healthier with Jersey Weight Loss Clinic, so he's not worried about extra ...

Should you, would you, take Ozempic? It's a question I'm asked by friends and it's a hot topic among my scientist colleagues, ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Time-restricted eating may improve blood glucose control and help reduce fat when coupled with standard nutritional ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.